HTLV, CMV, and EBV: Implications for Ocular Tissue Transplantation
Ocular tissues from donors with seropositivity to HTLV, CMV, and/or EBV can be used for transplantation per current EBAA guidelines. Despite the potential for ocular infection by these viruses, there are no reported cases of viral transmission from ocular tissue transplantation, affirming the validity of the current EBAA guidelines.
Authors
- Shahzad I. Mian (ORCID: https://orcid.org/0000-0001-7563-5121)
- Asim V. Farooq (ORCID: https://orcid.org/0000-0002-4309-3353)
- Jennifer Li (ORCID: https://orcid.org/0000-0003-0186-8613)
- Andrea Crosson
- Winston Chamberlain (ORCID: https://orcid.org/0000-0003-0007-9428)
- Natalie Buckman
- Anthony John Aldave (ORCID: https://orcid.org/0000-0002-9082-4796)
- Jennifer DeMatteo
- Jim Wagner
Institutions
- W.K. Kellogg Foundation (US)
- Legacy Health (US)
- Oregon Health & Science University (US)
- University of Michigan (US)
- University of Chicago (US)
- SightLife (US)
- Eye Bank Association of America (US)
- Minnesota Lions Eye Bank (US)
- University of California, Davis (US)
Publication Details
- Journal
- Cornea
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1097/ico.0000000000004040
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00